Naprosyn and Eye allergy - a phase IV clinical study of FDA data

Summary:

Eye allergy is reported as a side effect among people who take Naprosyn (naproxen), especially for people who are female, 50-59 old, also take Neurontin, and have Neoplasm malignant.

The phase IV clinical study analyzes which people have Eye allergy when taking Naprosyn. It is created by eHealthMe based on reports of 16,337 people who have side effects when taking Naprosyn from the FDA, and is updated regularly.

What is Naprosyn?

Naprosyn has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 16,738 Naprosyn users. Check the latest studies of Naprosyn.

What is Eye allergy?

Eye allergy is found to be associated with 206 drugs and 284 conditions by eHealthMe. Check the latest studies of Eye allergy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

16,337 people reported to have side effects when taking Naprosyn.
Among them, 18 people (0.11%) have Eye allergy.

Among these 18 people:

What is the gender of people who have Eye allergy when taking Naprosyn? *

female: 88.89 %
male: 11.11 %

What is the age of people who have Eye allergy when taking Naprosyn? *

What are other drugs people take besides Naprosyn? *

Neurontin: 15 people, 83.33%
Methotrexate: 13 people, 72.22%
Versed: 13 people, 72.22%
Aredia: 13 people, 72.22%
Carboplatin: 13 people, 72.22%
Cytoxan: 13 people, 72.22%
Demerol: 13 people, 72.22%
Dexamethasone Sodium Phosphate: 13 people, 72.22%
Faslodex: 13 people, 72.22%
Gemzar: 13 people, 72.22%

What are other side effects people have besides Eye allergy? *

Stress And Anxiety: 14 people, 77.78%
Herpes Zoster: 14 people, 77.78%
Metastases To Spine (cancer spreads to spine): 13 people, 72.22%
Duodenogastric Reflux (bile flows upward from the small intestine into the stomach): 13 people, 72.22%
Metastases To Pelvis (cancer spreads to pelvis): 13 people, 72.22%
Metastases To Lung (cancer spreads to lung): 13 people, 72.22%
Metastases To Bone (cancer spreads to bone): 13 people, 72.22%
Deformity (disfigurement): 13 people, 72.22%
Osteolysis (dissolution of bone): 13 people, 72.22%
Osteonecrosis Of Jaw (death of bone of jaw): 13 people, 72.22%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 7 people, 38.89%
Neoplasm Malignant (cancer tumour): 7 people, 38.89%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 11.11%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 11.11%
Weight Decreased: 1 person, 5.56%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 5.56%
Nervousness: 1 person, 5.56%
Joint Swelling: 1 person, 5.56%
Joint Pain: 1 person, 5.56%
Inflammation: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Naprosyn and have Eye allergy?

- Check whether Eye allergy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Naprosyn:

Naprosyn (16,738 reports)

Eye allergy treatments and more:

Eye allergy (3,635 reports)

Browse all side effects of Naprosyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eye allergy:

Eye allergy (206 drugs)

Browse all the conditions that are associated with Eye allergy:

Eye allergy (284 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on naproxen (the active ingredients of Naprosyn) and Naprosyn (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.